Terms: = Germ cell tumor AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
844 results:
1. Ganglioglioma with
Zhao C; Li C; Ge JJ; Zhang JP
Br J Hosp Med (Lond); 2024 Oct; 85(10):1-10. PubMed ID: 39475028
[No Abstract] [Full Text] [Related]
2. Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.
Knudsen AM; Ewald JD; Pedersen V; Haupt-Jorgensen M; Hansen EVR; Kristensen BW
Neuropathol Appl Neurobiol; 2024 Oct; 50(5):e13012. PubMed ID: 39449228
[TBL] [Abstract] [Full Text] [Related]
3. Primary Mast cell Sarcoma of the Maxillary Sinus and Gingiva Mimicking Malignant Neuroendocrine tumor: A Case Report.
Cheng TC; Chen JR; Wang RC; Chang KC; Hang JF
Head Neck Pathol; 2024 Oct; 18(1):97. PubMed ID: 39404971
[TBL] [Abstract] [Full Text] [Related]
4. Automated manufacturing and characterization of clinical grade autologous cd20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Aleksandrova K; Leise J; Priesner C; Aktas M; Apel M; Assenmacher M; Bürger I; Richter A; Altefrohne P; Schubert C; Holzinger A; Barden M; Bezler V; von Bergwelt-Baildon M; Borchmann P; Goudeva L; Glienke W; Arseniev L; Esser R; Abken H; Koehl U
Front Immunol; 2024; 15():1328368. PubMed ID: 39386211
[TBL] [Abstract] [Full Text] [Related]
5. Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model.
Afsordeh N; Pournajaf S; Bayat H; Mohajerani F; Shojaei A; Mirnajafi-Zadeh J; Pourgholami MH
BMC Cancer; 2024 Sep; 24(1):1099. PubMed ID: 39232721
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib).
Kot M; Simiczyjew A; Wądzyńska J; Ziętek M; Matkowski R; Nowak D
Cell Commun Signal; 2024 Aug; 22(1):410. PubMed ID: 39175042
[TBL] [Abstract] [Full Text] [Related]
7. Combined underwater endoscopic and microscopic surgery for tympanic paraganglioma: A case report.
Takata Y; Anzai T; Sonoda K; Okada H; Ishimizu E; Nakamura M; Hara S; Nakayama T; Matsumoto F
Sci Prog; 2024; 107(3):368504241263524. PubMed ID: 39043202
[TBL] [Abstract] [Full Text] [Related]
8. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases.
Wu Z; Dazelle K; Abdullaev Z; Chung HJ; Dahiya S; Wood M; Lee H; Lucas CG; Mao Q; Robinson L; Fernandes I; McCord M; Pytel P; Conway KS; Yoda R; Eschbacher JM; Maher OM; Hasselblatt M; Mobley BC; Raisanen JM; Hatanpaa KJ; Byers J; Lehman NL; Cimino PJ; Pratt D; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Jul; 12(1):117. PubMed ID: 39014393
[TBL] [Abstract] [Full Text] [Related]
9. Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway.
Luan W; Lu X; Peng H; Shen X; Rao M; Ruan H
Pathol Res Pract; 2024 Aug; 260():155410. PubMed ID: 38955119
[TBL] [Abstract] [Full Text] [Related]
10. The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin-derived deteriorated tumors.
Gong W; Zhou J; Hou Y; Zhang J; He P; Yu Q
Skin Res Technol; 2024 Jul; 30(7):e13774. PubMed ID: 38953214
[TBL] [Abstract] [Full Text] [Related]
11. CD40 agonist engineered immunosomes modulated tumor microenvironment and showed pro-immunogenic response, reduced toxicity, and tumor free survival in mice bearing glioblastoma.
Gaur V; Tyagi W; Das S; Ganguly S; Bhattacharyya J
Biomaterials; 2024 Dec; 311():122688. PubMed ID: 38943821
[TBL] [Abstract] [Full Text] [Related]
12. Regulation and molecular mechanism of adiponectin on the proliferation, apoptosis, autophagy, and chemosensitivity of LN18 Glioma cell line.
Sun P; Huo K; Liu F; Cheng Y; Chen C; Han J; Yu J
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):178-186. PubMed ID: 38836664
[TBL] [Abstract] [Full Text] [Related]
13. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
Ceci C; Ruffini F; Falconi M; Atzori MG; Falzon A; Lozzi F; Iacovelli F; D'Atri S; Graziani G; Lacal PM
Biomed Pharmacother; 2024 Jul; 176():116766. PubMed ID: 38788599
[TBL] [Abstract] [Full Text] [Related]
15. Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis.
Barbosa LC; Machado GC; Heringer M; Ferrer VP
Neurogenetics; 2024 Jul; 25(3):249-262. PubMed ID: 38775886
[TBL] [Abstract] [Full Text] [Related]
16. Genomic medicine advances for brain tumors.
Koizumi S; Oishi T; Iwaizumi M; Kurozumi K
Int J Clin Oncol; 2024 Oct; 29(10):1407-1416. PubMed ID: 38727852
[TBL] [Abstract] [Full Text] [Related]
17. Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer cell Lines.
Soleiman M; Fathi-Roudsari M; Khajeh K; Maghsoudi A
Cancer Invest; 2024 Apr; 42(4):319-332. PubMed ID: 38695671
[TBL] [Abstract] [Full Text] [Related]
18. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
[TBL] [Abstract] [Full Text] [Related]
19. LKB1 prevents ILC2 exhaustion to enhance antitumor immunity.
Niu H; Zhang H; Wang D; Zhao L; Zhang Y; Zhou W; Zhang J; Su X; Sun J; Su B; Qiu J; Shen L
Cell Rep; 2024 May; 43(5):113579. PubMed ID: 38670109
[TBL] [Abstract] [Full Text] [Related]
20. Evaluating the human neurotoxicity and toxicological interactions impact of co-occurring regulated and emerging mycotoxins.
de Sá SVM; Sousa Monteiro C; Fernandes JO; Pinto E; Faria MA; Cunha SC
Food Res Int; 2024 May; 184():114239. PubMed ID: 38609220
[TBL] [Abstract] [Full Text] [Related]
[Next]